The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vase K B Christ
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 4.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vase K B Christ, a non-promoter acquirer, has been allotted 17,59,002 equity shares of Samsrita Labs Ltd on July 18, 2025 through a preferential issue on a swap basis. This represents 7.73% of the company's total voting share capital, taking the acquirer's holding from nil to 7.73%. The company's total equity share capital expanded from 1,48,08,706 to 2,27,49,710 shares following this allotment. The filing is a revised disclosure under the SEBI Takeover Regulations, and the shares were acquired through a preferential allotment rather than open market purchase.
A non-promoter entity acquiring a 7.73% stake via share-swap preferential allotment introduces a sizeable new shareholder and dilutes existing holders by roughly 35% in share count terms. Investors should note the acquirer is approaching the 10% SAST disclosure threshold and watch for any further acquisitions that could trigger open offer obligations.